Transmedics Grp Stock
StockStockPrice
Frequently asked questions
What is Transmedics Grp's market capitalization?
What is Transmedics Grp's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Transmedics Grp?
What are the analyst ratings and target price for Transmedics Grp's stock?
What is Transmedics Grp's revenue over the trailing twelve months?
What is the EBITDA for Transmedics Grp?
What is the free cash flow of Transmedics Grp?
What is the 5-year beta of Transmedics Grp's stock?
How many employees does Transmedics Grp have, and what sector and industry does it belong to?
What is the free float of Transmedics Grp's shares?
Financials
Market Cap
$2.75B5Y beta
2.07EPS (TTM)
$0.939Free Float
32.50MP/E ratio (TTM)
87.31Revenue (TTM)
$401.09MEBITDA (TTM)
$49.16MFree Cashflow (TTM)
-$120.51MPricing
Analyst Ratings
The price target is $136.14 and the stock is covered by 9 analysts.
Buy
8
Hold
1
Sell
0
Information
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
584
Medical Equipment & Supplies
Health Care
Identifier
ISIN
Primary Ticker